tradingkey.logo
tradingkey.logo
Search

ProKidney Corp

PROK
Add to Watchlist
1.680USD
+0.030+1.82%
Close 09-24 16:00(ET)
507.46MMarket Cap
LossP/E TTM

PROK Cash Flow Statement

You can access the annual and quarterly cash flow statements of ProKidney Corp to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-28.51%-40.37M
-40.86%-41.68M
-34.51%-32.51M
9.05%-26.60M
17.96%-31.42M
14.59%-29.59M
4.78%-24.17M
-22.98%-29.24M
-156.72%-38.29M
-33.29%-34.65M
-61.06%-25.38M
-4.09%-23.78M
35.22%-14.92M
-68.14%-25.99M
-21.33%-15.76M
-25.41%-22.84M
-94.49%-23.03M
-113.05%-15.46M
---12.99M
---18.21M
---11.84M
---7.26M
Net income from continuing operations
-25.62%-46.44M
-12.30%-42.62M
15.74%-40.85M
12.69%-35.84M
3.90%-36.97M
-7.41%-37.95M
-123.18%-48.48M
2.23%-41.05M
-10.46%-38.47M
4.27%-35.33M
11.59%-21.72M
-23.70%-41.99M
-57.35%-34.82M
45.31%-36.91M
-79.76%-24.57M
-98.02%-33.95M
-73.92%-22.13M
-481.32%-67.49M
---13.67M
---17.14M
---12.72M
---11.61M
Operating gains losses
14.54%1.68M
3.62%1.66M
16.71%1.84M
-70.76%1.99M
15.35%1.47M
45.19%1.60M
37.35%1.57M
577.61%6.81M
45.98%1.27M
32.45%1.10M
44.88%1.15M
28.35%1.00M
15.69%870.00K
17.18%832.00K
34.75%791.00K
50.87%783.00K
45.45%752.00K
96.68%710.00K
--587.00K
--519.00K
--517.00K
--361.00K
Other non-cash items
----
----
----
--318.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Change in working capital
49.55%-954.00K
-571.97%-5.25M
-95.69%757.00K
584.01%1.30M
74.86%-1.89M
119.16%1.11M
349.55%17.55M
-104.57%-269.00K
-180.66%-7.52M
-137.49%-5.81M
524.92%3.91M
7.60%5.89M
196.64%9.32M
-78.93%-2.45M
-1020.73%-919.00K
410.02%5.47M
-5073.20%-9.65M
-135.81%-1.37M
---82.00K
---1.77M
--194.00K
--3.82M
-Change in receivables
430.43%76.00K
-86.33%95.00K
-95.86%110.00K
122.85%538.00K
97.27%-23.00K
231.38%695.00K
501.82%2.66M
-131.93%-2.35M
67.71%-844.00K
90.34%-529.00K
---661.00K
--7.38M
---2.61M
---5.48M
----
----
----
----
----
----
----
----
-Change in prepaid expenses
13.92%1.68M
-89.37%609.00K
-161.52%-1.56M
125.48%593.00K
121.90%1.47M
915.78%5.73M
668.16%2.53M
-181.99%-2.33M
-398.14%-6.73M
--564.00K
68.61%-446.00K
679.18%2.84M
142.41%2.26M
----
-178.16%-1.42M
-115.92%-490.00K
-8.66%-5.32M
----
--1.82M
--3.08M
---4.90M
----
-Change in payables and accrued expense
-21.76%-2.71M
-0.93%-5.96M
-81.58%2.16M
-99.11%51.00K
-2238.46%-2.22M
0.67%-5.90M
202.87%11.71M
222.94%5.72M
-99.20%104.00K
-888.69%-5.94M
625.14%3.87M
-1067.98%-4.66M
739.09%13.03M
-139.57%-601.00K
-85.99%533.00K
109.93%481.00K
-138.19%-2.04M
-57.43%1.52M
--3.80M
---4.84M
--5.34M
--3.57M
-Change in other current assets
----
----
----
----
----
----
----
----
----
----
----
----
-13.75%-3.48M
190.63%3.48M
----
--6.91M
-1129.72%-3.06M
-1643.37%-3.84M
---5.70M
----
---249.00K
--249.00K
Cash from non-recurring investing activities
Cash from operating activities
-28.51%-40.37M
-40.86%-41.68M
-34.51%-32.51M
9.05%-26.60M
17.96%-31.42M
14.59%-29.59M
4.78%-24.17M
-22.98%-29.24M
-156.72%-38.29M
-33.29%-34.65M
-61.06%-25.38M
-4.09%-23.78M
35.22%-14.92M
-68.14%-25.99M
-21.33%-15.76M
-25.41%-22.84M
-94.49%-23.03M
-113.05%-15.46M
---12.99M
---18.21M
---11.84M
---7.26M
Investing cash flow
Net cash from continuing investing activities
23.17%3.83M
233.48%3.79M
-148.86%-12.46M
116.18%5.20M
389.31%3.11M
18.23%1.14M
1522.71%25.51M
-91.40%2.40M
-82.81%636.00K
-2.64%960.00K
413.73%1.57M
8769.52%27.94M
858.55%3.70M
17.52%986.00K
-43.33%306.00K
-74.98%315.00K
-80.74%386.00K
-39.60%839.00K
--540.00K
--1.26M
--2.00M
--1.39M
Capital expenditures
23.17%3.83M
233.48%3.79M
-77.45%5.75M
116.18%5.20M
389.31%3.11M
18.23%1.14M
1522.71%25.51M
-91.40%2.40M
-82.81%636.00K
-2.64%960.00K
413.73%1.57M
8769.52%27.94M
858.55%3.70M
17.52%986.00K
-43.33%306.00K
-74.98%315.00K
-80.74%386.00K
-39.60%839.00K
--540.00K
--1.26M
--2.00M
--1.39M
Net cash flow from disposal of fixed assets
23.17%3.83M
233.48%3.79M
-148.86%-12.46M
116.18%5.20M
389.31%3.11M
18.23%1.14M
1522.71%25.51M
-91.40%2.40M
-82.81%636.00K
-2.64%960.00K
413.73%1.57M
8769.52%27.94M
858.55%3.70M
17.52%986.00K
-43.33%306.00K
-74.98%315.00K
-80.74%386.00K
-39.60%839.00K
--540.00K
--1.26M
--2.00M
--1.39M
Net cash flow from intangible asset transactions
----
----
---18.21M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net cash flow from investment products
-23.24%16.64M
31.23%38.61M
-61.49%15.63M
143.18%34.22M
-25.78%21.68M
-50.43%29.42M
143.06%40.59M
-18114.02%-79.23M
408.96%29.21M
130.98%59.36M
---94.27M
---435.00K
---9.45M
---191.63M
----
----
----
----
----
----
----
----
Net cash flow from other investing activities
--0.00
--0.00
--0.00
--0.00
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
--108.00K
----
----
--1.00K
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
-31.02%12.81M
23.11%34.83M
86.29%28.09M
135.55%29.02M
-35.02%18.57M
-51.56%28.29M
115.73%15.08M
-187.71%-81.64M
317.21%28.57M
130.32%58.40M
-31221.57%-95.84M
-13607.25%-28.37M
-3307.51%-13.15M
-22857.33%-192.61M
43.23%-306.00K
83.56%-207.00K
80.74%-386.00K
39.60%-839.00K
---539.00K
---1.26M
---2.00M
---1.39M
Financing cash flow
Cash flow from continuous financing activities
3964.29%541.00K
1891.67%215.00K
14236.59%17.63M
78.66%7.96M
-100.01%-14.00K
7.69%-12.00K
101.29%123.00K
34376.92%4.46M
1075807.69%139.84M
0.00%-13.00K
-118800.00%-9.51M
-100.00%-13.00K
-100.08%-13.00K
-100.05%-13.00K
-100.03%-8.00K
4315.69%507.50M
55.04%15.49M
27.75%25.54M
--29.99M
--11.49M
--9.99M
--19.99M
Net cash flow from debt Issuance/repayment
64.29%-5.00K
75.00%-3.00K
64.29%-5.00K
----
-7.69%-14.00K
7.69%-12.00K
-7.69%-14.00K
-7.69%-14.00K
0.00%-13.00K
0.00%-13.00K
-62.50%-13.00K
99.96%-13.00K
-100.09%-13.00K
-100.07%-13.00K
0.00%-8.00K
-500014.29%-35.01M
187500.00%14.99M
285700.00%19.99M
---8.00K
---7.00K
---8.00K
---7.00K
Net cash flow from common stock issuance/repurchase
--0.00
--7.00K
571600.00%17.14M
58.88%7.10M
----
----
99.97%-3.00K
--4.47M
--139.85M
----
---9.50M
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-95.00%500.00K
-72.25%5.55M
--30.00M
--11.50M
--10.00M
--20.00M
Proceeds from stock option exercised by employees
--546.00K
--211.00K
252.86%494.00K
--854.00K
----
----
--140.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net cash flow from other financing activities
--0.00
--0.00
100.00%0.00
--5.00K
----
----
---3.00K
----
----
----
----
----
----
----
----
--542.50M
----
----
----
----
----
----
Net cash from non-recurrent financing activities
Net cash from financing activities
3964.29%541.00K
1891.67%215.00K
14236.59%17.63M
78.66%7.96M
-100.01%-14.00K
7.69%-12.00K
101.29%123.00K
34376.92%4.46M
1075807.69%139.84M
0.00%-13.00K
-118800.00%-9.51M
-100.00%-13.00K
-100.08%-13.00K
-100.05%-13.00K
-100.03%-8.00K
4315.69%507.50M
55.04%15.49M
27.75%25.54M
--29.99M
--11.49M
--9.99M
--19.99M
Net cash flow
Beginning cash balance
4.18%101.89M
9.50%108.54M
-11.81%95.32M
-60.40%84.94M
15.90%97.81M
63.43%99.12M
-43.52%108.09M
-11.93%214.51M
-82.79%84.39M
-87.63%60.65M
-62.20%191.39M
1013.03%243.55M
1545.03%490.25M
2284.73%490.25M
12264.52%506.33M
81.22%21.88M
87.13%29.80M
349.16%20.56M
--4.09M
--12.07M
--15.93M
--4.58M
Current period cash flow changes
-110.08%-27.03M
-405.10%-6.64M
247.35%13.21M
109.76%10.38M
-109.89%-12.87M
-105.54%-1.31M
93.14%-8.97M
-104.01%-106.42M
563.35%130.12M
110.86%23.74M
-713.31%-130.74M
-110.77%-52.16M
-254.57%-28.08M
-2464.96%-218.62M
-197.64%-16.07M
6170.74%484.44M
-105.66%-7.92M
-18.54%9.24M
--16.46M
---7.98M
---3.85M
--11.35M
Ending cash balance
-11.86%74.87M
4.18%101.89M
9.50%108.54M
-11.81%95.32M
-60.40%84.94M
15.90%97.81M
63.43%99.12M
-43.52%108.09M
-53.59%214.51M
-68.93%84.39M
-87.63%60.65M
-62.20%191.39M
2012.10%462.17M
811.47%271.63M
2284.73%490.25M
12264.52%506.33M
81.22%21.88M
87.14%29.80M
--20.56M
--4.09M
--12.07M
--15.93M
Free cash flow
-28.03%-44.21M
-47.98%-45.47M
22.98%-38.27M
-0.47%-31.79M
11.31%-34.53M
13.70%-30.73M
-84.30%-49.68M
38.81%-31.64M
-109.12%-38.93M
-31.98%-35.61M
-67.77%-26.96M
-123.32%-51.72M
20.49%-18.62M
-65.53%-26.98M
-18.75%-16.07M
-18.92%-23.16M
-69.13%-23.41M
-88.53%-16.30M
---13.53M
---19.47M
---13.84M
---8.64M
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

What is operating cash flow?

Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did ProKidney Corp Generate?

ProKidney Corp generated -120.12M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did ProKidney Corp's Operating Cash Flow Change Year Over Year?

ProKidney Corp's operating cash flow increased by 4.93% year over year.

What is investing cash flow?

Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does ProKidney Corp Spend on Capital Expenditures?

ProKidney Corp spent 15.20M on capital expenditures in the most recent quarter。

What is financing cash flow?

Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has ProKidney Corp's Financing Cash Flow Changed?

ProKidney Corp used 25.57M in financing activities in the latest quarter.

What is free cash flow and why does it matter for PROK?

Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was ProKidney Corp’s free cash flow in the latest quarter?

Free cash flow was -135.31M reflecting a 13.18% change from the previous year.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.